Paul M. Silva, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 11,330 shares at $211.82 ($2.4M) on 2021-02-18, disclosed to the SEC on 2021-02-19.
Seasonal sale ($2.4M) by SVP & Chief Accounting Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $211.75 | 2,740 | $580K | 24.2% |
| 2 | $210.05 | 584 | $123K | 5.1% |
| 3 | $210.05 | 584 | $123K | 5.1% |
| 4 | $211.82 | 2,343 | $496K | 20.7% |
| 5 | $211.82 | 2,343 | $496K | 20.7% |
| 6 | $212.62 | 1,368 |
| $291K |
| 12.1% |
| 7 | $212.62 | 1,368 | $291K | 12.1% |
| Total | $211.81 avg | 11,330 | $2.4M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |
| VRTX | SELL | 2020-08-05 | $431K | — | Filing → |